11 – 14 of 14
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- « previous
- 1
- 2
- next »
- 2009
-
Mark
The Impact of Quadrivalent Human Papillomavirus (HPV; Types 6, 11, 16, and 18) L1 Virus-Like Particle Vaccine on Infection and Disease Due to Oncogenic Nonvaccine HPV Types in Generally HPV-Naive Women Aged 16-26 Years
(
- Chapter in Book/Report/Conference proceeding › Paper in conference proceeding
- 2008
-
Mark
Strengthening prevention programs to eliminate cervical cancer in the Nordic countries.
(
- Contribution to journal › Scientific review
-
Mark
HPV antibody levels and clinical efficacy following administration of a prophylactic quadrivalent HPV vaccine
(
- Contribution to journal › Article
- 2007
-
Mark
Quadrivalent vaccine against human papillomavirus to prevent high-grade cervical lesions
(
- Contribution to journal › Article
- « previous
- 1
- 2
- next »